Merck's Covid drug is causing new virus mutations, study warns
US and UK researchers identified new mutations in viral samples taken from dozens of patients given Merck's antiviral Lagevrio. These mutations were not deemed to be dangerous.
US and UK researchers identified new mutations in viral samples taken from dozens of patients given Merck's antiviral Lagevrio. These mutations were not deemed to be dangerous.
